InsidersTradesSigma
瑞康医药: directors' dealings · France · AMF
SZSE:002589FR·AMFMcap 4.8Bn€
Explore the full management transaction log of 瑞康医药, a listed issuer based in France. Shares are quoted on FR FR, under the oversight of AMF. Market capitalisation: €4.8bn. The latest transaction was disclosed on 21 June 2024 — Purchase. Among the most active insiders: 张仁华. All data is accessible without an account.
6
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
5 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3.02 €
Income statement
Revenue7.30 Bn€
Gross profit776.1 M€11% margin
Net income16.1 M€0.2% margin
Balance sheet & cash
Market cap4.85 Bn€
Total debt4.60 Bn€
Free Cash Flow−13.1 M€
Last declaration on 21 June 2024
Declarations6 total
Executives●Purchase7SZSE
2,638,600 shares
A股XSHE
SZSE:173000007779437440·
Ideal exit: 18 Mar 2025 (T+270)
6 of 6 declarations